Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Lind

Showing results (231-240 of 826) with videos related to

Pageof 83
Sort By:
Atherosclerosis|July 24, 2015
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosisLars Lind, Johan Ärnlöv, Bertil Lindahl, et al.
Metabolic Syndrome and Related Disorders|October 19, 2016
Metabolic Syndrome Development During Aging with Special Reference to Obesity Without the Metabolic SyndromeVendela Roos, Sölve Elmståhl, Erik Ingelsson, et al.
Diabetologia|August 26, 2019
In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional studyKristina Beijer, Christoph Nowak, Johan Sundström, et al.
Scientific Reports|August 10, 2020
Self-reported difficulty initiating sleep and early morning awakenings are associated with nocturnal diastolic non-dipping in older white Swedish menXiao Tan, Lars Lind, Martin Ingelsson, et al.
Environmental Research|September 1, 2014
Persistent organic pollutants are related to the change in circulating lipid levels during a 5 year follow-upJohanna Penell, Lars Lind, Samira Salihovic, et al.
Stroke|November 7, 2015
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics ChipLars Lind, Agneta Siegbahn, Bertil Lindahl, et al.
Circulation|April 29, 2015
Response to letter regarding article, "Discontinuation of smokeless tobacco and mortality risk after myocardial infarction"Gabriel Arefalk, Kristina Hambraeus, Lars Lind, et al.
Journal of Clinical Medicine|May 11, 2024
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Increased Glomerular Production or Permeability in Diabetes Mellitus?Shengyuan Xu, Anders Larsson, Lars Lind, et al.
Clinical and Experimental Pharmacology & Physiology|June 13, 2002
Effects of blockade of alpha- and beta-adrenoceptors and neuropeptide Y(1) receptors, as well as brachial plexus blockade, on endothelium-dependent vasodilation in the human forearmKristina Johansson, Mats Eriksson, Inger Wahlqvist, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and functionHelena Brändström, Fredrik Stiger, Lars Lind, et al.
Pageof 83

Showing results (231-240 of 826) with videos related to

Sort By:
Pageof 83
Atherosclerosis|July 24, 2015
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosisLars Lind, Johan Ärnlöv, Bertil Lindahl, et al.
Metabolic Syndrome and Related Disorders|October 19, 2016
Metabolic Syndrome Development During Aging with Special Reference to Obesity Without the Metabolic SyndromeVendela Roos, Sölve Elmståhl, Erik Ingelsson, et al.
Diabetologia|August 26, 2019
In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional studyKristina Beijer, Christoph Nowak, Johan Sundström, et al.
Scientific Reports|August 10, 2020
Self-reported difficulty initiating sleep and early morning awakenings are associated with nocturnal diastolic non-dipping in older white Swedish menXiao Tan, Lars Lind, Martin Ingelsson, et al.
Environmental Research|September 1, 2014
Persistent organic pollutants are related to the change in circulating lipid levels during a 5 year follow-upJohanna Penell, Lars Lind, Samira Salihovic, et al.
Stroke|November 7, 2015
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics ChipLars Lind, Agneta Siegbahn, Bertil Lindahl, et al.
Circulation|April 29, 2015
Response to letter regarding article, "Discontinuation of smokeless tobacco and mortality risk after myocardial infarction"Gabriel Arefalk, Kristina Hambraeus, Lars Lind, et al.
Journal of Clinical Medicine|May 11, 2024
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Increased Glomerular Production or Permeability in Diabetes Mellitus?Shengyuan Xu, Anders Larsson, Lars Lind, et al.
Clinical and Experimental Pharmacology & Physiology|June 13, 2002
Effects of blockade of alpha- and beta-adrenoceptors and neuropeptide Y(1) receptors, as well as brachial plexus blockade, on endothelium-dependent vasodilation in the human forearmKristina Johansson, Mats Eriksson, Inger Wahlqvist, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and functionHelena Brändström, Fredrik Stiger, Lars Lind, et al.
Pageof 83